Vectorite Biomedical Deferred Tax Liabilities

4170.TWO

The Deferred Tax Liabilities of Vectorite Biomedical (4170.TWO) as of Nov 5, 2026 is 19,000.00 TWD.

Get this data via API

Financial Data API

Deferred Tax Liabilities

19,000.00TWD

Last updated: Nov 5, 2026

Deferred Tax Liabilities of Vectorite Biomedical is 2014 19,000.00 TWD. Deferred Tax Liabilities of Vectorite Biomedical was 2013 - TWD. It decreases by % lower compared to the previous year.

The Vectorite Biomedical Deferred Tax Liabilities history

The Vectorite Biomedical Deferred Tax Liabilities history
YEAR	Deferred Tax Liabilities	YoY
2014	19,000.00TWD	—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Docs Get Free API Key

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Xinpin Biomedical Co., Ltd. established Xinpin Biomedical Group with the concept of “preventing problems before it happens” and is headquartered in Taipei, New Taipei. The firm offers a range of services including immune cell collection, processing and storage, cell preparation safety testing, anti-cancer immunity testing, original design manufacturer or contract development and manufacturing organization services, related medical consulting, and laboratory quality management. Its product portfolio features dendritic cell vaccines and natural killer cell preparations designed for cancer treatment. Products are mainly sold domestically. Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

What is the Vectorite Biomedical Deferred Tax Liabilities 2014?

Deferred Tax Liabilities of Vectorite Biomedical is 19,000.00 TWD in 2014.

How has Vectorite Biomedical Deferred Tax Liabilities developed historically?

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

What is the Vectorite Biomedical Deferred Tax Liabilities?

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

How does Vectorite Biomedical Deferred Tax Liabilities affect the stock price?

Deferred Tax Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's Vectorite Biomedical historically and in real time.

Vectorite Biomedical Deferred Tax Liabilities

The Vectorite Biomedical Deferred Tax Liabilities history

Vectorite Biomedical Stock analysis

Frequently Asked Questions about Vectorite Biomedical stock

What is the Vectorite Biomedical Deferred Tax Liabilities 2014?

How has Vectorite Biomedical Deferred Tax Liabilities developed historically?

What is the Vectorite Biomedical Deferred Tax Liabilities?

How does Vectorite Biomedical Deferred Tax Liabilities affect the stock price?

Balance Sheet — Vectorite Biomedical

All Key Metrics — Vectorite Biomedical

Valuation

Income Statement

Margins

Balance Sheet

Cash Flow

Profitability

Leverage

Growth

Dividend

Workforce

Quality

Other